STOCK TITAN

Vogenx: OrbiMed entities report 6.5% holding

Available on EDGAR Accepted by SEC EDGAR Learn about SEC filing dates
(Neutral)

Sentiment and the balance of points

Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.

Form Type
SCHEDULE 13G

Rhea-AI Filing Summary

Vogenx, Inc. (VOGX) had two reporting entities disclose beneficial ownership of its common stock as of September 30, 2026. OrbiMed Advisors LLC reported 647,633 shares (4.4%), with shared voting and dispositive power; OrbiMed Capital LLC reported 320,988 shares (2.2%), with sole voting and dispositive power. The entities stated that, in aggregate, they held 6.5% of the common stock on behalf of other persons.

Beneficial ownership — OrbiMed Advisors LLC 647,633 shares 4.4% of the class as of September 30, 2026; shared voting and dispositive power.
Class percentage — OrbiMed Advisors LLC 4.4% Reported beneficial ownership as of September 30, 2026.
Beneficial ownership — OrbiMed Capital LLC 320,988 shares 2.2% of the class as of September 30, 2026; sole voting and dispositive power.
Class percentage — OrbiMed Capital LLC 2.2% Reported beneficial ownership as of September 30, 2026.
Shares held on behalf of other persons 6.5% The reporting entities stated they held this aggregate share percentage on behalf of other persons.
beneficial ownership regulatory
"Amount beneficially owned"
Beneficial ownership means the person or entity that actually enjoys the benefits of owning shares or other assets — such as receiving dividends, voting rights, or price gains — even if the legal title is held in another name. For investors it matters because knowing who truly controls and profits from a company reveals who can influence decisions, exposes potential conflicts of interest or hidden concentration of power, and affects transparency and risk in the stock.
shared voting power regulatory
"Shared voting power 647,633.00"
Shared voting power occurs when two or more parties jointly have the right to vote or decide how a block of company shares is cast, like co-owners who must agree before moving a piece of furniture. Investors care because who controls voting rights affects board elections, major corporate decisions and takeover outcomes, and shared control can alter regulatory disclosures and the practical influence any holder has over a company’s direction and value.
shared dispositive power regulatory
"Shared dispositive power 647,633.00"
sole voting power regulatory
"Sole voting power 320,988.00"
Sole voting power is the exclusive right to cast votes attached to a shareholder’s stock without needing approval from anyone else. Like holding the only remote control for a TV, it lets that holder decide corporate matters such as board members, mergers, and policy changes, making it important to investors because it concentrates control and can strongly influence a company’s strategy and the value of its shares.
sole dispositive power regulatory
"Sole dispositive power 320,988.00"
Sole dispositive power is the exclusive legal authority to decide what happens to a security — for example, whether to sell, transfer, or retain shares — without needing anyone else’s permission. Investors care because it signals who truly controls the economic outcome of an investment: like holding the only key to a safe, the holder can realize gains or losses and may trigger regulatory reporting, insider rules, or influence over corporate ownership.

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

How many VOGX shares did the OrbiMed entities report owning?

As of September 30, 2026, OrbiMed Advisors LLC reported beneficial ownership of 647,633 Vogenx shares, or 4.4%, and OrbiMed Capital LLC reported 320,988 shares, or 2.2%. Advisors reported shared voting and dispositive power; Capital reported sole voting and dispositive power.

Who exercises voting power over OrbiMed's VOGX shares?

OrbiMed Advisors LLC and OrbiMed Capital LLC said they exercise investment and voting power through a management committee comprising Carl L. Gordon, W. Carter Neild, and Geoffrey C. Hsu. Each committee member disclaims beneficial ownership of the reported shares.

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google
Add on Google





92859A106

(CUSIP Number)
09/30/2026

(Date of Event Which Requires Filing of this Statement)


Check the appropriate box to designate the rule pursuant to which this Schedule is filed:
Rule 13d-1(b)
Rule 13d-1(c)
Rule 13d-1(d)




schemaVersion:


SCHEDULE 13G





SCHEDULE 13G





SCHEDULE 13G



OrbiMed Advisors LLC
Signature:/s/ Carl L. Gordon
Name/Title:Carl L. Gordon / Member
Date:11/16/2026
OrbiMed Capital LLC
Signature:/s/ Carl L. Gordon
Name/Title:Carl L. Gordon / Member
Date:11/16/2026

Keep reading